Skip to main content
. 2022 Mar 31;19(1):224–235. doi: 10.14245/ns.2143084.542

Table 1.

Comparison of clinical outcomes between satisfied and dissatisfied subgroups at short-term follow-up by univariate analysis

Variable All patients (n=226) Functional improvement (n = 226)
Relief of back pain
Relief of leg pain
Satisfied (n=158) Dissatisfied (n=68) p-value Satisfied (n=202) Dissatisfied (n=24) p-value Satisfied (n=199) Dissatisfied (n=27) p-value
ODI score
Baseline 45.3 ± 20.1 49.6 ± 21.0 35.6 ± 13.6 < 0.001** 45.6 ± 20.1 43.4 ± 20.5 0.615 46.1 ± 20.0 40.1 ± 20.6 0.148
At 3 months 12.3 ± 12.6 7.1 ± 6.7 24.2 ± 14.8 < 0.001** 10.3 ± 10.4 28.7 ± 17.1 < 0.001** 9.8 ± 9.6 30.6 ± 16.1 < 0.001**
SF-36 PF score
Baseline 51.7 ± 23.8 47.8 ± 24.8 60.7 ± 18.5 < 0.001** 51.7 ± 23.6 51.5 ± 26.3 0.967 50.6 ± 23.4 59.3 ± 25.5 0.077*
At 3 months 90.3 ± 12.6 93.8 ± 6.4 82.1 ± 18.3 < 0.001** 92.2 ± 7.7 73.8 ± 26.5 0.002** 92.7 ± 6.7 72.6 ± 25.7 < 0.001**
SF-36 BP score
Baseline 46.5 ± 19.3 43.9 ± 20.3 52.5 ± 15.3 0.002** 46.0 ± 19.6 50.5 ± 16.5 0.286 45.6 ± 19.5 53.1 ± 16.7 0.058*
At 3 months 87.1 ± 14.0 91.9 ± 8.7 75.9 ± 17.4 < 0.001** 89.8 ± 10.3 63.8 ± 19.0 < 0.001** 90.2 ± 9.2 64.2 ± 20.8 < 0.001**
EQ-5D score
Baseline 0.52 ± 0.23 0.48 ± 0.25 0.62 ± 0.14 < 0.001** 0.52 ± 0.24 0.56 ± 0.15 0.365 0.51 ± 0.23 0.58 ± 0.19 0.137
At 3 months 0.90 ± 0.13 0.94 ± 0.09 0.82 ± 0.18 < 0.001** 0.93 ± 0.10 0.72 ± 0.22 < 0.001** 0.93 ± 0.09 0.71 ± 0.22 < 0.001**
VAS-back score
Baseline 3.96 ± 2.47 3.99 ± 2.55 3.90 ± 2.31 0.815 3.80 ± 2.51 5.30 ± 1.60 < 0.001** 3.85 ± 2.49 4.82 ± 2.24 0.056*
At 3 months 0.95 ± 1.29 0.66 ± 0.92 1.63 ± 1.71 < 0.001** 0.60 ± 0.70 3.96 ± 1.20 < 0.001** 0.68 ± 0.84 2.96 ± 2.07 < 0.001**
VAS-leg score
Baseline 5.43 ± 2.00 5.67 ± 2.03 4.86 ± 1.81 0.005** 5.42 ± 2.00 5.50 ± 2.04 0.856 5.46 ± 2.04 5.19 ± 1.69 0.500
At 3 months 0.96 ± 1.43 0.51 ± 0.83 2.02 ± 1.91 < 0.001** 0.68 ± 1.04 3.29 ± 2.07 < 0.001** 0.52 ± 0.70 4.19 ± 1.33 < 0.001**

Values are presented as mean±standard deviation.

ODI, Oswestry Disability Index; SF-36 PF; 36-item Short Form Health Survey physical function; SF-36 BP, 36-item Short Form Health Survey bodily pain; EQ-5D, European quality of life-5 dimensions; VAS, visual analogue scale.

*

p<0.1.

**

p<0.05.